Webinar: The Importance of Fast Biomarker Testing in Breast Cancer

Watch our FREE Breast Cancer Webinar now!

Program:

• Testing Breast Cancer Specimen for Biomarkers: Current Workup and Future Expectations: Dr. Claus Hann von Weyhern from the Pathology Service at Munich Klinik

• ESR1 Mutation Testing  in Metastatic Breast Cancers: Therapeutic Implications: Prof. Daniele Generali, MD DPhil from the University of Trieste, Breast Cancer Unit - ASST of Cremona (Italy)

• PIK3K as Important Targetable Pathway in Recurrent ER-Positive, HER2-Negative Breast Cancer: Prof Dr. Sigurd F. Lax from the Department of Pathology, General Hospital Graz West, Graz, Austria

• Q&A